Stay updated on Expanded Access to Upadacitinib Clinical Trial

Sign up to get notified when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Expanded Access to Upadacitinib Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Expanded Access page now lists additional eligible conditions for Upadacitinib (e.g., Hidradenitis Suppurativa, Vitiligo, Alopecia Areata, Systemic Lupus Erythematosus, Giant Cell Arteritis, Spondyloarthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Rheumatoid Arthritis) and updates related MeSH terms. Older date entries (2026-01-30, 2026-01-29, 2025-04) were removed.
    Difference
    5%
    Check dated 2026-08-24T15:57:42.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a small platform update to the UI/backend. No study details or user actions are altered by this change.
    Difference
    0.1%
    Check dated 2026-08-10T01:42:10.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.4 label, replacing the previous v3.6.3. This reflects a minor behind-the-scenes update to the site version rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-07-26T14:32:27.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.6.3 replaces the prior Revision: v3.6.2, reflecting a new site revision. This is a minor update to the page's revision metadata rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-05T04:41:19.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2, reflecting an underlying system/template update used to render the page.
    Difference
    0.1%
    Check dated 2026-06-27T23:35:39.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The Intervention/Treatment heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag updated from v3.5.5 to v3.6.0. New navigation entries such as 'Check who can join', 'Find Contact Information', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added to help users access guidance.
    Difference
    0.7%
    Check dated 2026-06-13T17:44:30.000Z thumbnail image

Stay in the know with updates to Expanded Access to Upadacitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.